ArticleBMC cancer2014

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study.

Gabriella Ferrandina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.